Title: Mechanisms of Graft Rejection: Lessons Learned from Pathology
1Mechanisms of Graft Rejection Lessons Learned
from Pathology
- Lorraine C. Racusen, M.D.
- The Johns Hopkins University
- Baltimore
2Rejection as an Inflammatory/Immune Process
3Cells Involved in/Diagnostic ofAcute Rejection
4Acute Rejection - cell-mediated
- The effector cells
- Morphology - mononuclear
- lymphocytic
- Immunophenotyping
- CD8 gt CD4 - ?/?, ?/?
- CD45RO gt RA
- perforin/granzyme/CD57 - cytotoxic cells
- Other cells - eosinophils
- plasma cells
5Acute Rejection - antibody mediated
- Effectors
- Complement
- Neutrophils
- Platelets
6Tissue Targets of the Acute Rejection Reaction
7Acute Rejection - cell-mediated
- The targets
- Vessels - arteries
- capillaries
- Parenchymal - tubules
- ducts
- myocardium
- hepatocytes
- acini
- bronchi
- crypts
8Antibody-mediated rejection
- The target
- Endothelium of arteries, capillaries
- HLA antigens - class I, class II,
- Endothelial antigens
9Antibody - mediated rejection
- Morphologic clues may lead to diagnosis
- Marginating cells - neutrophils, mononuclear
- Early/severe arteritis/fibrinoid necrosis
- Thromboses
- Hemorrhage/infarction
- Complement deposition
10Molecular mechanisms of Acute Rejection
11Acute Rejection - cell mediated
- The molecules
- Antigens/neo-antigens - Class II, Class I
- Adhesion molecules - V-CAM, I-CAM
- Cytokines - IL - 2
- Demonstrable by immunohistology, PCR
12Antibody-mediated rejection
- The molecules
- Antibodies - IgG (esp. IgG3), IgM
- Complement - new focus on C3d, C4d
13Mechanisms of Tissue Injury
14Acute Rejection
- Mechanisms of Tissue Injury
- Organ - Cytotoxicity
- Ischemia
- Cells - Sublethal Injury
- Necrosis
- Apoptosis
- Severity - Reversible
- Irreversible
15Concept of Tissue Priming for Rejection
16Acute Rejection - cell-mediated
- Targeting mechanisms
- ? or new expression of HLA antigens - DR
- ? expression of adhesion molecules
- I-CAM-1
- VCAM-1
- ? IFN-?, 1L-2 receptors
17Corollary Not all leukocytic infiltrates in
allografts are a response to allo-antigen
18Inflammation in the Allograft
- Pre-existing
- Ischemia
- Infection
- bacterial
- viral
- Drug reaction
- Neoplastic - PTLD
- Non-specific
- Acceptance reaction
19Acceptance Reactions
- Recognizable in experimental models
- T-lymphocytes and monocyte/macrophages
- no vasculitis, may be tubulitis
- less T cell activation, apoptosis than rejection
- ? interferon, ? IL-10 compared to rejection
- Cytotoxic cells present
- NOT BEING RECOGNIZED CLINICALLY
20Criteria for diagnosis of rejection
21Morphologic Bases of Diagnosis of Rejection
22The concept of subclinical rejection
23Morphologic predictors - of refractory
rejection of later functional loss
24Cells Involved in Chronic Rejection
25Acute Rejection
- Pathologic Findings Predicting Refractory
Rejection - Intimal arteritis
- Severe acute glomerulitis
- Necrotizing arteritis
- Interstitial hemorrhage
- Numerous eosinophils, plasma cells,
- monocyte/macrophages
- CD8 - rich infiltrate
26Cells involved in Chronic Rejection
27Chronic Rejection
- The Cells
- Monocyte/macrophage - IL2R
- Fibroblast/myofibroblast
- T cells - CD4
28Tissue Targets of Chronic Rejection
29Chronic Rejection
- The targets
- Parenchymal elements
- most closely correlated with outcome
- the final common pathway
- Arteries
- lesions often not sampled on Bx
- Capillary lesions
- better sampled
30Molecular Mechanisms of Chronic Rejection
31Chronic Rejection
- The Molecules
- Fibrogenic Factors
- TGF, FGF, PDGF
- Macrophage-associated
- RANTES, MCP-1, IL-6
- Cytokines
- IFN, TNF
32Molecular Pathology of Acute and Chronic
Rejection
33Not all chronic change in the allograft
represents a chronic alloimmune response
34Causes of fibrosis in the allograft
- Chronic rejection
- Infection
- Drug toxicity
- Atherosclerosis/hypertensive
- vascular disease
- Obstruction
- Recurrent disease
- Donor-related
35Early Prediction
- Rejection too patchy a process for biopsy to be
useful
36Critical Pathologic Data
- Nature of infiltrates
- Localization of infiltrates
- Predictive features
- Differential diagnoses
- Molecular milieu